Protecting children from nerve agents
Published: October 4,2013
By Wally Northway
While Mississippi State University scientists work on an antidote for nerve agents for use by the military, the federal government is looking for nerve agent treatments for children.
According to a release from the U.S. Department of Health and Human Services, an effective, faster-acting and longer-lasting pediatric medication to treat seizures caused by nerve agents will be studied and purchased under a Project BioShield contract from HHS’ Office of the Assistant Secretary for Preparedness and Response.
There are no currently approved medications to treat seizures caused by nerve agents, HHS reports.
Under a five-year, $60-million contract, Meridian Medical Technologies Inc. of Columbia, Md., a Pfizer company, will conduct studies of midazolam to seek approval from the U.S. Food and Drug Administration for the drug’s use in treating seizures caused by nerve agents. Meridian also will seek FDA approval of a midazolam auto-injector for children and adults, and seek approval of midazolam for use in treating common prolonged seizures.
To sign up for Mississippi Business Daily Updates, click here.
One Response to “Protecting children from nerve agents”
Top Posts & Pages
- Analyst: KiOR Columbus plant may end up sold as scrap
- (UPDATE) Gov. Bryant: $1.2 billion aluminum plant is a very exciting proposition for the state of Mississippi
- College Board gives Keenum contract extension, raise
- Humana and Bill, Hillary and Chelsea Clinton Foundation partnering
- Six out of eight universities could have higher tuitions in 2015
- WILLOUGHBY: Bernie Reed cites hard work as key to success of Reed’s Metals
- Can Metrocenter rise from the ashes? Again
- Hunting deer? There's an app for that
- Apple ordered to pay $23.6M for using SkyTel technology
- Gulf oil rig explosion kills one worker, injures three